The AIG Hospitals today announced the launch of the ZAP-X®[?] Gyroscopic Neuro-Radiosurgery Platform, the first installation of its kind in South India and only the second in the country, marking a major advancement in the treatment of brain tumours and complex neurological disorders.
Glioblastoma is an extremely aggressive brain tumour that is currently incurable. Cancer doctors can increase their patients' life expectancy with surgeries, radiation, chemotherapy, or surgical procedures. Nonetheless, half of patients die within a year of diagnosis.
According to a recent study, medications intended to treat blood and other malignancies may also increase the effectiveness of radiation therapy for low-grade brain tumours in adults.
A research group at the University of Seville's Department of Biochemistry and Molecular Biology has achieved great progress by identifying the critical role of the protein Galectin-3 in the progression of several forms of brain tumours.
The Apollo Hospital in Delhi, which has been the forerunner of healthcare and challenged limits to providing exceptional care, has unveiled ZAP-X, an innovative technology designed for the treatment of brain tumours in sessions lasting 30 minutes.
The innovative device, which is the size and shape of a grain of rice, can perform hundreds of studies at the same time to examine the impact of novel treatments on some of the most difficult-to-treat brain tumours.
Researchers from Brigham and Women's Hospital, a founding member of the Mas
For the first time, researchers discovered a potential drug candidate that improved outcomes for patients suffering from a type of childhood brain tumour that has no effective treatment. When compared to previous patients, the compound, called ONC201, nearly doubled survival for patients wit
Folate-based radiopharmaceuticals can be used in positron emission tomography (PET) imaging to identify folate receptors in brain tumours. The identification of folate receptors and its potential application in brain tumours is a fresh and significant scientific breakthrough.
To detect folate receptors in brain tumours, folate-based radiopharmaceuticals can be utilised in positron emission tomography (PET) imaging. The identification of folate receptors and their possible application in brain tumours is a novel and major development in the science.
Children with recurrent brain tumours tolerated the first in-human trial of a novel immunotherapy well, and many were able to experience unexpected months of a more normal life, according to researchers. Immunotherapy disables a natural enzyme that tumours hijack for their defence.
A very uncommon but frequently aggressive type of brain tumour called a glioma may be caused by damage, according to key molecular research from the UCL Cancer Centre. Although there may be a connection between head trauma and an increase in brain tumour incidence, the evidence is conflictin
Researching the wall separating the circulatory system from the neurological system has been highly difficult or limited in its use of models. In order to properly investigate potential new treatments for brain tumours, researchers have created a more realistic model.